China Sky One Medical to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai

HARBIN, China, March 2, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that Mr. Hongyu Pan, the Company's Chief Financial Officer, will attend the Rodman & Renshaw Annual China Investment Conference to be held from March 6-8, 2011 in Shanghai.

The date, time, and location of China Sky One Medical's presentation at the Conference are as follows:

The Rodman & Renshaw's 2011 Annual China Investment Conference will feature diverse industry sectors, including Agriculture, Automotive, Clean Tech & Energy, Consumer, Education, Healthcare, Industrial, Metals & Mining, and Technology. The conference is expected to attract over 150 public and private companies and more than 1,000 attendees. For more information about the conference and registration, please visit www. www.rodm.com/conferences.  

Investors who wish to meet with China Sky One Medical's management may contact Rodman & Renshaw or their IR representative in the U.S., Mabel Zhang at +1-310)-954-1353 or mabel.zhang@ccgir.com.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio-Engineering Company Limited, Heilongjiang Tianlong Pharmaceutical, Inc. and Peng Lai Jin Chuang Pharmaceutical Company, the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn.